Camazepam

Camazepam is a benzodiazepine. Camazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. Camazepam is a benzodiazepine that is a dimethyl carbamate ester of tamzepam, a metabolite of diazepam. Similarly to other drugs in its class, it has antxiolytic, anticonvulsant, hypnotic, and skeletal muscle relaxant properties. However, unlike other benzodiapeines camazepam is predominantly anxiolytic and is relatively weak as an anticonvulsant, hypnotic and skeletal muscle relaxant. Camazepam also has less side effects, including impaired cognition and reaction times, compared to other benzodiazepines. However, impairment of cognition and disrupted sleep patterns will occur at doses higher than 40mg of carazepam. Camazepam is also believed to increase attention, and is associated with skin disorders. In the United States camazepam is regulated as a Schedule IV controlled substance. a benzodiazepine used as a minor tranquilizer; it is the dimethyl carbamate salt of temazepam. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Albego, Paxor, Limpidon and Camazepamum. Its PubChem CID is 37367.

CAS No 36104-80-0
Molecular Formula C19H18ClN3O3
Molecular Weight 371.8 g/mol
Synonyms (7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl) N,N-dimethylcarbamate

Frequently Asked Questions